ask="4.51"
ask_size="5000"
average_daily_volume="299252"
bid="3.98"
bid_size="1700"
book_value="0.56"
change="+0.02"
change_from_200_day_moving_average="1.41"
change_from_50_day_moving_average="0.54"
change_from_52_week_high="-0.61"
change_From_52_week_low="2.03"
change_in_percent="+0.49%"
close="4.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.14"
high_52_weeks="4.70"
last_trade_date="3/14/2017"
last_trade_price="4.09"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.99"
low_52_weeks="2.06"
market_capitalization="76.43M"
moving_average_200_day="2.68"
moving_average_50_day="3.55"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="4.06"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+52.42%"
percent_change_from_50_day_moving_average="+15.34%"
percent_change_from_52_week_high="-12.98%"
percent_change_from_52_week_low="+98.53%"
previous_close="4.07"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.23"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="5.44"
stock_exchange="NCM"
symbol="BCLI"
volume="25325"
weeks_range_52="2.06 - 4.70"
